EQL Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	78.26	82.4	20.47	44.43	41.2	26.58
Cash & Short-Term Investments	78.26	82.4	20.47	44.43	41.2	26.58
Cash Growth	561.60%	302.58%	-53.93%	7.83%	55.01%	157.80%
Accounts Receivable	91.13	130.72	60.77	51.7	34.1	22.08
Other Receivables	22.25	1.4	5.21	0.96	0.71	4.22
Receivables	113.38	132.12	65.98	52.66	34.81	26.3
Inventory	203.25	179.03	105.63	65.37	41.67	42.36
Prepaid Expenses	-	6.25	4.75	4.2	2.24	0.32
Other Current Assets	-	0.45	0.94	0.57	3.53	2.27
Total Current Assets	394.89	400.25	197.77	167.23	123.45	97.82
Property, Plant & Equipment	5.46	6.33	2.67	3.15	4.19	5.01
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	424.84	364.67	149.08	102.54	98.41	93.68
Long-Term Deferred Tax Assets	-	-	-	-	-	0.3
Long-Term Deferred Charges	-	37.58	24.24	12.78	11.83	6.7
Other Long-Term Assets	-0	-0	-	-	-	-
Total Assets	825.18	808.82	373.76	285.7	237.89	203.51
Accounts Payable	66.97	90.94	49.83	29.61	15.98	19.03
Accrued Expenses	-	10.29	6.65	17.87	16.28	4.48
Short-Term Debt	105.94	107.41	102.22	63.7	59.32	64.41
Current Portion of Long-Term Debt	-	4.11	-	-	5.4	5.4
Current Portion of Leases	-	2.75	1.4	1.21	-	-
Current Income Taxes Payable	-	-	-	0.14	-	-
Other Current Liabilities	21.96	1.53	1.43	4.66	1.64	1.48
Total Current Liabilities	194.87	221.02	162.05	117.19	98.76	94.93
Long-Term Debt	342.42	338.39	15.45	-	7.2	12.6
Long-Term Leases	-	3.05	1.02	1.71	4.18	4.76
Long-Term Deferred Tax Liabilities	27.89	25.34	17.51	12.05	4.12	-
Other Long-Term Liabilities	0	0	-	0	-	-
Total Liabilities	565.19	587.79	196.03	130.94	114.26	112.29
Common Stock	260	1.31	1.31	1.31	1.31	1.31
Additional Paid-In Capital	-	67.64	67.45	67.18	66.99	66.13
Retained Earnings	-	152.08	108.97	86.26	55.33	23.78
Comprehensive Income & Other	-	-	-0	-	-	-
Shareholders' Equity	260	221.03	177.73	154.75	123.63	91.22
Total Liabilities & Equity	825.18	808.82	373.76	285.7	237.89	203.51
Total Debt	448.37	455.71	120.09	66.62	76.1	87.17
Net Cash (Debt)	-370.1	-373.31	-99.63	-22.19	-34.9	-60.59
Net Cash Per Share	-12.20	-12.49	-3.34	-0.75	-1.20	-2.08
Filing Date Shares Outstanding	29.53	29.06	29.06	29.06	29.06	29.06
Total Common Shares Outstanding	29.53	29.06	29.06	29.06	29.06	29.06
Working Capital	200.02	179.23	35.72	50.04	24.7	2.89
Book Value Per Share	8.80	7.61	6.12	5.32	4.25	3.14
Tangible Book Value	-164.84	-143.63	28.65	52.21	25.21	-2.46
Tangible Book Value Per Share	-5.58	-4.94	0.99	1.80	0.87	-0.08
Machinery	-	4.47	3.17	0.99	2.14	1.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.